PSI Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,854
Closed -$296K 169
2025
Q1
$296K Buy
4,854
+304
+7% +$17.7K 0.1% 96
2024
Q4
$257K Sell
4,550
-1,400
-24% -$78.2K 0.08% 117
2024
Q3
$308K Sell
5,950
-780
-12% -$36.6K 0.09% 104
2024
Q2
$279K Buy
6,730
+694
+11% +$31.1K 0.09% 111
2024
Q1
$327K Buy
6,036
+196
+3% +$9.98K 0.12% 101
2023
Q4
$300K Sell
5,840
-376
-6% -$19.7K 0.11% 104
2023
Q3
$361K Buy
6,216
+1,091
+21% +$66.8K 0.16% 87
2023
Q2
$328K Buy
5,125
+473
+10% +$31.7K 0.14% 91
2023
Q1
$322K Buy
4,652
+1
+0% +$71 0.16% 86
2022
Q4
$335K Sell
4,651
-4,037
-46% -$304K 0.18% 83
2022
Q3
$618K Sell
8,688
-3,889
-31% -$282K 0.32% 60
2022
Q2
$968K Sell
12,577
-613
-5% -$46.7K 0.48% 45
2022
Q1
$963K Sell
13,190
-2,166
-14% -$145K 0.4% 52
2021
Q4
$958K Sell
15,356
-749
-5% -$43.9K 0.39% 54
2021
Q3
$953K Sell
16,105
-253
-2% -$16.7K 0.44% 45
2021
Q2
$1.09M Buy
16,358
+256
+2% +$16.7K 0.58% 40
2021
Q1
$1.02M Buy
16,102
+2,736
+20% +$170K 0.6% 42
2020
Q4
$829K Buy
13,366
+1,696
+15% +$104K 0.57% 37
2020
Q3
$703K Buy
11,670
+402
+4% +$24.2K 0.54% 38
2020
Q2
$662K Buy
11,268
+2,351
+26% +$141K 0.53% 45
2020
Q1
$497K Sell
8,917
-767
-8% -$46.9K 0.46% 51
2019
Q4
$621K Buy
+9,684
New +$555K 0.4% 49

Other funds holding BMY

PSI Advisors's BMY Position: Q2 2025 in Review

PSI Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 4,854 shares — an estimated $296K sold.

PSI Advisors first reported a position in BMY in Q4 2019 and held it in 22 quarters. The position peaked at $1.09M in Q2 2021. 2,298 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • PSI Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • PSI Advisors sold 4,854 Bristol-Myers Squibb shares in Q2 2025, an estimated $296K.
  • PSI Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 22 quarters.
  • PSI Advisors's Bristol-Myers Squibb position peaked at $1.09M in Q2 2021.
  • 2,298 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on PSI Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.